Innovating Works

ASOCIACION DE ESCLEROSIS MULTIPLE DE TOL...

Desconocido
IMMUTOL: ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED... ASOCIACION DE ESCLEROSIS MULTIPLE DE TOLEDO participó en un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Autoimmune diseases are currently treated with immunosuppressive and supportive therapies, which dampen inflammation, but do not stop the ca...
2023-04-14 - 2027-04-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.